Aswin A. Pai
Vellore, TN, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Improving breast cancer treatments using pharmacomicrobiomics.
Journal: mBio
Published: January 17, 2025
Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies.
Journal: Stem cell research & therapy
Published: August 12, 2024
Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation.
Journal: Clinical pharmacology and therapeutics
Published: August 07, 2023
Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 28, 2023
Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editors.
Journal: Molecular therapy. Nucleic acids
Published: April 28, 2023
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo.
Journal: Frontiers in pharmacology
Published: March 15, 2023
Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies.
Journal: Molecular therapy. Nucleic acids
Published: December 17, 2022
Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges.
Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges.
Journal: Frontiers in immunology
Published: November 16, 2022
Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2.
Journal: Frontiers in genome editing
Published: October 31, 2022
Endothelial Activation and Stress Index-Measured Pretransplantation Predicts Transplantation-Related Mortality in Patients with Thalassemia Major Undergoing Transplantation with Thiotepa, Treosulfan, and Fludarabine Conditioning.
Journal: Transplantation and cellular therapy
Published: February 11, 2022
Last Updated: 09/26/2026